Gelteq Limited Ordinary Shares (GELS) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Gelteq Limited Ordinary Shares (GELS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $4.0M, listed on NASDAQ, employing roughly 7 people, carrying a beta of 0.08 to the broader market. Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. Led by Nathan Jacob Givoni, public since 2024-10-29.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for GELS as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →